Search research articles
Contact Us
Filters
Showing results (1191-1200 of 1,501) with videos related to
Page
of 151
Sort By:
Genes, Chromosomes & Cancer
|
May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma
Ioannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
Genomics
|
March 20, 1995
Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata
M S Fejzo, S J Yoon, K T Montgomery, et al.
British Journal of Cancer
|
November 29, 2019
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Mengyuan Huang, Wenyu Yang, Jiaqing Zhu, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 12, 2022
High Sensitivity of Mobile Phone Microscopy Screening for Schistosoma haematobium in Azaguié, Côte d'Ivoire
Jean T Coulibaly, Kigbafori D Silue, Maxim Armstrong, et al.
Circulation
|
August 30, 2024
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Lauren Heath, et al.
Current Protocols in Human Genetics
|
April 3, 2016
Reporting of Diagnostic Cytogenetic Results
Anne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Oncology Reports
|
January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers
A V Mitra, C Jameson, Y Barbachano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers
Suzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Oncogene
|
September 23, 2018
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
Lillian R Klug, Amber E Bannon, Nathalie Javidi-Sharifi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 5, 2013
Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement
Cheng-Han Lee, Lien N Hoang, Stephen Yip, et al.
Page
of 151
Search research articles
Search
Showing results (1191-1200 of 1,501) with videos related to
Sort By:
Page
of 151
Genes, Chromosomes & Cancer
|
May 13, 2004
The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma
Ioannis Panagopoulos, Clelia Tiziana Storlazzi, Christopher D M Fletcher, et al.
Genomics
|
March 20, 1995
Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata
M S Fejzo, S J Yoon, K T Montgomery, et al.
British Journal of Cancer
|
November 29, 2019
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
Mengyuan Huang, Wenyu Yang, Jiaqing Zhu, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 12, 2022
High Sensitivity of Mobile Phone Microscopy Screening for Schistosoma haematobium in Azaguié, Côte d'Ivoire
Jean T Coulibaly, Kigbafori D Silue, Maxim Armstrong, et al.
Circulation
|
August 30, 2024
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
Brendon L Neuen, Robert A Fletcher, Lauren Heath, et al.
Current Protocols in Human Genetics
|
April 3, 2016
Reporting of Diagnostic Cytogenetic Results
Anne B S Giersch, Frederick R Bieber, Adrian M Dubuc, et al.
Oncology Reports
|
January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers
A V Mitra, C Jameson, Y Barbachano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers
Suzanne George, Margaret von Mehren, Jonathan A Fletcher, et al.
Oncogene
|
September 23, 2018
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
Lillian R Klug, Amber E Bannon, Nathalie Javidi-Sharifi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 5, 2013
Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement
Cheng-Han Lee, Lien N Hoang, Stephen Yip, et al.
Page
of 151